治療用RNAiのトップ5メーカー分析(北米、欧州、アジア、南米、中東、アフリカ)

LP Informationが発行した調査報告書(LPI705109)
◆英語タイトル:2017 Top 5 RNAi for Therapeutic Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa
◆商品コード:LPI705109
◆発行会社(リサーチ会社):LP Information
◆発行日:2017年5月2日
◆ページ数:128
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD4,960 ⇒換算¥560,480見積依頼/購入/質問フォーム
Corporate UserUSD9,920 ⇒換算¥1,120,960見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

This report studies RNAi for Therapeutic in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 RNAi for Therapeutic Players in each region, with sales, price, revenue and market share for top 5 manufacturer, covering Alnylam Pharmaceuticals
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
miRagen Therapeutics
Gradalis
Sirnaomics

Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top 5 players in these regions, from 2012 to 2017 (forecast), like
North America (United States, Canada and Mexico)
Asia-Pacific (China, Japan, Southeast Asia, India and Korea)
Europe (Germany, UK, France, Italy and Russia etc.
South America (Brazil, Chile, Peru and Argentina)
Middle East and Africa (Egypt, South Africa, Saudi Arabia)

Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
siRNA
miRNA
shRNA

Split by applications, this report focuses on sales, market share and growth rate of RNAi for Therapeutic in each application, can be divided into
Cancer
Cardiovascular
HBV
Other

【レポートの目次】

Table of Contents

2017 Top 5 RNAi for Therapeutic Manufacturers/Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
1 RNAi for Therapeutic Market Overview
1.1 Product Overview and Scope of RNAi for Therapeutic
1.2 RNAi for Therapeutic Segment by Types
1.2.1 Global Sales Market Share of RNAi for Therapeutic by Types in 2015
1.2.2 siRNA
1.2.3 miRNA
1.2.4 shRNA
1.3 RNAi for Therapeutic Segment by Applications
1.3.1 RNAi for Therapeutic Consumption Market Share by Applications in 2015
1.3.2 Cancer
1.3.3 Cardiovascular
1.3.4 HBV
1.3.5 Other
1.4 RNAi for Therapeutic Market by Regions
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Asia-Pacific Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 South America Status and Prospect (2012-2022)
1.4.5 Middle East and Africa Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of RNAi for Therapeutic (2012-2022)
2 Global RNAi for Therapeutic Sales, Revenue (value) and Market Share by Players
2.1 Global RNAi for Therapeutic Sales and Market Share in 2015 and 2016 by Players
2.2 Global RNAi for Therapeutic Revenue and Market Share by Players in 2015 and 2016
2.3 Global RNAi for Therapeutic Average Price by Players in 2015 and 2016
2.4 Global RNAi for Therapeutic Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 RNAi for Therapeutic Market Competitive Situation and Trends
2.5.1 RNAi for Therapeutic Market Concentration Rate
2.5.2 RNAi for Therapeutic Market Share of Top 3 and Top 5 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Global RNAi for Therapeutic Sales, Revenue (Value) by Regions, Type and Application (2012-2017)
3.1 Global RNAi for Therapeutic Sales, Revenue and Market Share by Regions (2012-2017)
3.1.1 Global RNAi for Therapeutic Sales and Market Share by Regions (2012-2017)
3.1.2 Global RNAi for Therapeutic Revenue and Market Share by Regions (2012-2017)
3.2 Global RNAi for Therapeutic Sales, Revenue, Market Share and Price by Type (2012-2017)
3.2.1 Global RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
3.2.2 Global RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
3.2.3 Global RNAi for Therapeutic Price by Type (2012-2017)
3.3 Global RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
3.4 Global RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
4 North America Top 5 Players RNAi for Therapeutic Sales, Revenue and Price
4.1 North America Top 5 Players RNAi for Therapeutic Sales, Revenue and Market Share in 2015 and 2016
4.1.1 North America Top 5 Players RNAi for Therapeutic Sales and Market Share in 2015 and 2016
4.1.2 North America Top 5 Players RNAi for Therapeutic Revenue and Market Share in 2015 and 2016
4.2 North America RNAi for Therapeutic Sales, Revenue, Market Share and Price by Type (2012-2017)
4.2.1 North America RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
4.2.2 North America RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
4.2.3 North America RNAi for Therapeutic Price by Type (2012-2017)
4.3 North America RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
4.4 North America RNAi for Therapeutic Sales and Market Share by Country (US, Canada and Mexico) (2012-2017)
4.5 North America RNAi for Therapeutic Import & Export (2012-2017)
5 Europe Top 5 Players RNAi for Therapeutic Sales, Revenue and Price
5.1 Europe Top 5 Players RNAi for Therapeutic Sales, Revenue and Market Share in 2015 and 2016
5.1.1 Europe Top 5 Players RNAi for Therapeutic Sales and Market Share in 2015 and 2016
5.1.2 Europe Top 5 Players RNAi for Therapeutic Revenue and Market Share in 2015 and 2016
5.2 Europe RNAi for Therapeutic Sales, Revenue, Market Share and Price by Type (2012-2017)
5.2.1 Europe RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
5.2.2 Europe RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
5.2.3 Europe RNAi for Therapeutic Price by Type (2012-2017)
5.3 Europe RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
5.4 Europe RNAi for Therapeutic Sales and Market Share by Country (Germany, UK, France, Italy and Russia) (2012-2017)
5.5 Europe RNAi for Therapeutic Import & Export (2012-2017)
6 Asia-Pacific Top 5 Players RNAi for Therapeutic Sales, Revenue and Price
6.1 Asia-Pacific Top 5 Players RNAi for Therapeutic Sales, Revenue and Market Share in 2015 and 2016
6.1.1 Asia-Pacific Top 5 Players RNAi for Therapeutic Sales and Market Share in 2015 and 2016
6.1.2 Asia-Pacific Top 5 Players RNAi for Therapeutic Revenue and Market Share in 2015 and 2016
6.2 Asia-Pacific RNAi for Therapeutic Sales, Revenue, Market Share and Price by Type (2012-2017)
6.2.1 Asia-Pacific RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
6.2.2 Asia-Pacific RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
6.2.3 Asia-Pacific RNAi for Therapeutic Price by Type (2012-2017)
6.3 Asia-Pacific RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
6.4 Asia-Pacific RNAi for Therapeutic Sales and Market Share by Country (China, Japan, Southeast Asia, India and Korea) (2012-2017)
6.5 Asia-Pacific RNAi for Therapeutic Import & Export (2012-2017)
7 South America Top 5 Players RNAi for Therapeutic Sales, Revenue and Price
7.1 South America Top 5 Players RNAi for Therapeutic Sales, Revenue and Market Share in 2015 and 2016
7.1.1 South America Top 5 Players RNAi for Therapeutic Sales and Market Share in 2015 and 2016
7.1.2 South America Top 5 Players RNAi for Therapeutic Revenue and Market Share in 2015 and 2016
7.2 South America RNAi for Therapeutic Sales, Revenue, Market Share and Price by Type (2012-2017)
7.2.1 South America RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
7.2.2 South America RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
7.2.3 South America RNAi for Therapeutic Price by Type (2012-2017)
7.3 South America RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
7.4 South America RNAi for Therapeutic Sales and Market Share by Country (Brazil, Argentina, Chile and Peru) (2012-2017)
7.5 South America RNAi for Therapeutic Import & Export (2012-2017)
8 Middle East & Africa Top 5 Players RNAi for Therapeutic Sales, Revenue and Price
8.1 Middle East & Africa Top 5 Players RNAi for Therapeutic Sales, Revenue and Market Share in 2015 and 2016
8.1.1 Middle East & Africa Top 5 Players RNAi for Therapeutic Sales and Market Share in 2015 and 2016
8.1.2 Middle East & Africa Top 5 Players RNAi for Therapeutic Revenue and Market Share in 2015 and 2016
8.2 Middle East & Africa RNAi for Therapeutic Sales, Revenue, Market Share and Price by Type (2012-2017)
8.2.1 Middle East & Africa RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
8.2.2 Middle East & Africa RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
8.2.3 Middle East & Africa RNAi for Therapeutic Price by Type (2012-2017)
8.3 Middle East & Africa RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
8.4 Middle East & Africa RNAi for Therapeutic Sales and Market Share by Country (Egypt, Saudi Arabia, South Africa and Iran) (2012-2017)
8.5 Middle East & Africa RNAi for Therapeutic Import & Export (2012-2017)
9 Global RNAi for Therapeutic Players Profiles/Analysis
9.1 Alnylam Pharmaceuticals
9.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.1.2 RNAi for Therapeutic Product Types, Application and Specification
9.1.2.1 Type 1
9.1.2.2 Type 2
9.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Arrowhead
9.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.2.2 RNAi for Therapeutic Product Types, Application and Specification
9.2.2.1 Type 1
9.2.2.2 Type 2
9.2.3 Arrowhead RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Dicerna Pharmaceuticals
9.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.3.2 RNAi for Therapeutic Product Types, Application and Specification
9.3.2.1 Type 1
9.3.2.2 Type 2
9.3.3 Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Mirna Therapeutics
9.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.4.2 RNAi for Therapeutic Product Types, Application and Specification
9.4.2.1 Type 1
9.4.2.2 Type 2
9.4.3 Mirna Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Quark Pharmaceuticals
9.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.5.2 RNAi for Therapeutic Product Types, Application and Specification
9.5.2.1 Type 1
9.5.2.2 Type 2
9.5.3 Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 RXi Pharmaceuticals
9.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.6.2 RNAi for Therapeutic Product Types, Application and Specification
9.6.2.1 Type 1
9.6.2.2 Type 2
9.6.3 RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 miRagen Therapeutics
9.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.7.2 RNAi for Therapeutic Product Types, Application and Specification
9.7.2.1 Type 1
9.7.2.2 Type 2
9.7.3 miRagen Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Gradalis
9.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.8.2 RNAi for Therapeutic Product Types, Application and Specification
9.8.2.1 Type 1
9.8.2.2 Type 2
9.8.3 Gradalis RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Sirnaomics
9.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.9.2 RNAi for Therapeutic Product Types, Application and Specification
9.9.2.1 Type 1
9.9.2.2 Type 2
9.9.3 Sirnaomics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
10 RNAi for Therapeutic Manufacturing Cost Analysis
10.1 RNAi for Therapeutic Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Expenses
10.3 Manufacturing Process Analysis of RNAi for Therapeutic
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 RNAi for Therapeutic Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of RNAi for Therapeutic Major Players in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global RNAi for Therapeutic Market Forecast (2017-2022)
14.1 Global RNAi for Therapeutic Sales, Revenue Forecast (2017-2022)
14.2 Global RNAi for Therapeutic Sales, Consumption Forecast by Regions (2017-2022)
14.3 Global RNAi for Therapeutic Sales Forecast by Type (2017-2022)
14.4 Global RNAi for Therapeutic Sales Forecast by Application (2017-2022)
14.5 RNAi for Therapeutic Price Forecast (2017-2022)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Analyst Introduction
16.3 Data Source

List of Tables and Figures

Figure Picture of RNAi for Therapeutic
Table Product Specifications of RNAi for Therapeutic
Figure Global Sales Market Share of RNAi for Therapeutic by Types in 2015
Table Types of RNAi for Therapeutic
Figure Product Picture of siRNA
Table Major Players of siRNA
Figure Product Picture of miRNA
Table Major Players of miRNA
Figure Product Picture of shRNA
Table Major Players of shRNA
Table RNAi for Therapeutic Consumption Market Share by Applications in 2015
Table Applications of RNAi for Therapeutic
Figure Cancer Examples
Figure Cardiovascular Examples
Figure HBV Examples
Figure Other Examples
Figure North America RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure South America RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East and Africa RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Table Global RNAi for Therapeutic Sales by Players in 2015 and 2016
Table Global RNAi for Therapeutic Sales Market Share (%) by Players in 2015 and 2016
Figure Global RNAi for Therapeutic Sales Share by Players in 2015
Figure Global RNAi for Therapeutic Sales Share by Players in 2016
Table Global RNAi for Therapeutic Revenue by Players in 2015 and 2016
Table Global RNAi for Therapeutic Revenue Market Share (%) by Players in 2015 and 2016
Figure Global RNAi for Therapeutic Revenue Share by Players in 2015
Figure Global RNAi for Therapeutic Revenue Share by Players in 2016
Table Global RNAi for Therapeutic Average Price by Players in 2015 and 2016
Table Global RNAi for Therapeutic Average Price by Players in 2016
Table Global RNAi for Therapeutic Manufacturing Base Distribution and Sales Area by Players
Table Players RNAi for Therapeutic Product Types
Figure RNAi for Therapeutic Market Share of Top 3 Players
Figure RNAi for Therapeutic Market Share of Top 5 Players
Table Global RNAi for Therapeutic Sales by Regions (2012-2017)
Table Global RNAi for Therapeutic Sales and Market Share by Regions (2012-2017)
Figure Global RNAi for Therapeutic Sales Market Share by Regions (2012-2017)
Figure 2016 Global RNAi for Therapeutic Sales Market Share by Regions
Table Global RNAi for Therapeutic Revenue by Regions (2012-2017)
Table Global RNAi for Therapeutic Revenue and Market Share by Regions (2012-2017)
Figure Global RNAi for Therapeutic Revenue Market Share by Regions (2012-2017)
Figure 2016 Global RNAi for Therapeutic Revenue Market Share by Regions
Table Global RNAi for Therapeutic Sales by Type (2012-2017)
Table Global RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
Figure Global RNAi for Therapeutic Sales Market Share by Type (2012-2017)
Figure 2016 Global RNAi for Therapeutic Sales Market Share by Type
Table Global RNAi for Therapeutic Revenue by Type (2012-2017)
Table Global RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
Figure Global RNAi for Therapeutic Revenue Market Share by Type (2012-2017)
Figure 2016 Global RNAi for Therapeutic Revenue Market Share by Type
Table Global RNAi for Therapeutic Price by Type (2012-2017)
Table Global RNAi for Therapeutic Sales by Application (2012-2017)
Table Global RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
Figure Global RNAi for Therapeutic Sales Market Share by Application (2012-2017)
Figure 2016 Global RNAi for Therapeutic Sales Market Share by Application
Table Global RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Table North America Top 5 Players RNAi for Therapeutic Sales in 2015 and 2016
Table North America Top 5 Players RNAi for Therapeutic Sales Market Share (%) in 2015 and 2016
Figure North America Top 5 Players RNAi for Therapeutic Sales Share in 2015
Figure North America Top 5 Players RNAi for Therapeutic Sales Share in 2016
Table North America Top 5 Players RNAi for Therapeutic Revenue in 2015 and 2016
Table North America Top 5 Players RNAi for Therapeutic Revenue Market Share (%) in 2015 and 2016
Figure North America Top 5 Players RNAi for Therapeutic Revenue Share in 2015
Figure North America Top 5 Players RNAi for Therapeutic Revenue Share in 2016
Table North America RNAi for Therapeutic Sales by Type (2012-2017)
Table North America RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
Figure North America RNAi for Therapeutic Sales Market Share by Type (2012-2017)
Figure 2016 North America RNAi for Therapeutic Sales Market Share by Type
Table North America RNAi for Therapeutic Revenue by Type (2012-2017)
Table North America RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
Figure North America RNAi for Therapeutic Revenue Market Share by Type (2012-2017)
Figure 2016 North America RNAi for Therapeutic Revenue Market Share by Type
Table North America RNAi for Therapeutic Price by Type (2012-2017)
Table North America RNAi for Therapeutic Sales by Application (2012-2017)
Table North America RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
Figure North America RNAi for Therapeutic Sales Market Share by Application (2012-2017)
Figure 2016 North America RNAi for Therapeutic Sales Market Share by Application
Table North America RNAi for Therapeutic Sales by Country (2012-2017)
Table North America RNAi for Therapeutic Sales Market Share by Country (2012-2017)
Figure North America RNAi for Therapeutic Sales Market Share by Country (2012-2017)
Figure 2016 North America RNAi for Therapeutic Sales Market Share by Country
Table North America RNAi for Therapeutic Import & Export (2012-2017)
Table Europe Top 5 Players RNAi for Therapeutic Sales in 2015 and 2016
Table Europe Top 5 Players RNAi for Therapeutic Sales Market Share (%) in 2015 and 2016
Figure Europe Top 5 Players RNAi for Therapeutic Sales Share in 2015
Figure Europe Top 5 Players RNAi for Therapeutic Sales Share in 2016
Table Europe Top 5 Players RNAi for Therapeutic Revenue in 2015 and 2016
Table Europe Top 5 Players RNAi for Therapeutic Revenue Market Share (%) in 2015 and 2016
Figure Europe Top 5 Players RNAi for Therapeutic Revenue Share in 2015
Figure Europe Top 5 Players RNAi for Therapeutic Revenue Share in 2016
Table Europe RNAi for Therapeutic Sales by Type (2012-2017)
Table Europe RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
Figure Europe RNAi for Therapeutic Sales Market Share by Type (2012-2017)
Figure 2016 Europe RNAi for Therapeutic Sales Market Share by Type
Table Europe RNAi for Therapeutic Revenue by Type (2012-2017)
Table Europe RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
Figure Europe RNAi for Therapeutic Revenue Market Share by Type (2012-2017)
Figure 2016 Europe RNAi for Therapeutic Revenue Market Share by Type
Table Europe RNAi for Therapeutic Price by Type (2012-2017)
Table Europe RNAi for Therapeutic Sales by Application (2012-2017)
Table Europe RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
Figure Europe RNAi for Therapeutic Sales Market Share by Application (2012-2017)
Figure 2016 Europe RNAi for Therapeutic Sales Market Share by Application
Table Europe RNAi for Therapeutic Sales by Country (2012-2017)
Table Europe RNAi for Therapeutic Sales Market Share by Country (2012-2017)
Figure Europe RNAi for Therapeutic Sales Market Share by Country (2012-2017)
Figure 2016 Europe RNAi for Therapeutic Sales Market Share by Country
Table Europe RNAi for Therapeutic Import & Export (2012-2017)
Table Asia-Pacific Top 5 Players RNAi for Therapeutic Sales in 2015 and 2016
Table Asia-Pacific Top 5 Players RNAi for Therapeutic Sales Market Share (%) in 2015 and 2016
Figure Asia-Pacific Top 5 Players RNAi for Therapeutic Sales Share in 2015
Figure Asia-Pacific Top 5 Players RNAi for Therapeutic Sales Share in 2016
Table Asia-Pacific Top 5 Players RNAi for Therapeutic Revenue in 2015 and 2016
Table Asia-Pacific Top 5 Players RNAi for Therapeutic Revenue Market Share (%) in 2015 and 2016
Figure Asia-Pacific Top 5 Players RNAi for Therapeutic Revenue Share in 2015
Figure Asia-Pacific Top 5 Players RNAi for Therapeutic Revenue Share in 2016
Table Asia-Pacific RNAi for Therapeutic Sales by Type (2012-2017)
Table Asia-Pacific RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
Figure Asia-Pacific RNAi for Therapeutic Sales Market Share by Type (2012-2017)
Figure 2016 Asia-Pacific RNAi for Therapeutic Sales Market Share by Type
Table Asia-Pacific RNAi for Therapeutic Revenue by Type (2012-2017)
Table Asia-Pacific RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
Figure Asia-Pacific RNAi for Therapeutic Revenue Market Share by Type (2012-2017)
Figure 2016 Asia-Pacific RNAi for Therapeutic Revenue Market Share by Type
Table Asia-Pacific RNAi for Therapeutic Price by Type (2012-2017)
Table Asia-Pacific RNAi for Therapeutic Sales by Application (2012-2017)
Table Asia-Pacific RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
Figure Asia-Pacific RNAi for Therapeutic Sales Market Share by Application (2012-2017)
Figure 2016 Asia-Pacific RNAi for Therapeutic Sales Market Share by Application
Table Asia-Pacific RNAi for Therapeutic Sales by Country (2012-2017)
Table Asia-Pacific RNAi for Therapeutic Sales Market Share by Country (2012-2017)
Figure Asia-Pacific RNAi for Therapeutic Sales Market Share by Country (2012-2017)
Figure 2016 Asia-Pacific RNAi for Therapeutic Sales Market Share by Country
Table Asia-Pacific RNAi for Therapeutic Import & Export (2012-2017)
Table South America Top 5 Players RNAi for Therapeutic Sales in 2015 and 2016
Table South America Top 5 Players RNAi for Therapeutic Sales Market Share (%) in 2015 and 2016
Figure South America Top 5 Players RNAi for Therapeutic Sales Share in 2015
Figure South America Top 5 Players RNAi for Therapeutic Sales Share in 2016
Table South America Top 5 Players RNAi for Therapeutic Revenue in 2015 and 2016
Table South America Top 5 Players RNAi for Therapeutic Revenue Market Share (%) in 2015 and 2016
Figure South America Top 5 Players RNAi for Therapeutic Revenue Share in 2015
Figure South America Top 5 Players RNAi for Therapeutic Revenue Share in 2016
Table South America RNAi for Therapeutic Sales by Type (2012-2017)
Table South America RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
Figure South America RNAi for Therapeutic Sales Market Share by Type (2012-2017)
Figure 2016 South America RNAi for Therapeutic Sales Market Share by Type
Table South America RNAi for Therapeutic Revenue by Type (2012-2017)
Table South America RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
Figure South America RNAi for Therapeutic Revenue Market Share by Type (2012-2017)
Figure 2016 South America RNAi for Therapeutic Revenue Market Share by Type
Table South America RNAi for Therapeutic Price by Type (2012-2017)
Table South America RNAi for Therapeutic Sales by Application (2012-2017)
Table South America RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
Figure South America RNAi for Therapeutic Sales Market Share by Application (2012-2017)
Figure 2016 South America RNAi for Therapeutic Sales Market Share by Application
Table South America RNAi for Therapeutic Sales by Country (2012-2017)
Table South America RNAi for Therapeutic Sales Market Share by Country (2012-2017)
Figure South America RNAi for Therapeutic Sales Market Share by Country (2012-2017)
Figure 2016 South America RNAi for Therapeutic Sales Market Share by Country
Table South America RNAi for Therapeutic Import & Export (2012-2017)
Table Middle East & Africa Top 5 Players RNAi for Therapeutic Sales in 2015 and 2016
Table Middle East & Africa Top 5 Players RNAi for Therapeutic Sales Market Share (%) in 2015 and 2016
Figure Middle East & Africa Top 5 Players RNAi for Therapeutic Sales Share in 2015
Figure Middle East & Africa Top 5 Players RNAi for Therapeutic Sales Share in 2016
Table Middle East & Africa Top 5 Players RNAi for Therapeutic Revenue in 2015 and 2016
Table Middle East & Africa Top 5 Players RNAi for Therapeutic Revenue Market Share (%) in 2015 and 2016
Figure Middle East & Africa Top 5 Players RNAi for Therapeutic Revenue Share in 2015
Figure Middle East & Africa Top 5 Players RNAi for Therapeutic Revenue Share in 2016
Table Middle East & Africa RNAi for Therapeutic Sales by Type (2012-2017)
Table Middle East & Africa RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
Figure Middle East & Africa RNAi for Therapeutic Sales Market Share by Type (2012-2017)
Figure 2016 Middle East & Africa RNAi for Therapeutic Sales Market Share by Type
Table Middle East & Africa RNAi for Therapeutic Revenue by Type (2012-2017)
Table Middle East & Africa RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
Figure Middle East & Africa RNAi for Therapeutic Revenue Market Share by Type (2012-2017)
Figure 2016 Middle East & Africa RNAi for Therapeutic Revenue Market Share by Type
Table Middle East & Africa RNAi for Therapeutic Price by Type (2012-2017)
Table Middle East & Africa RNAi for Therapeutic Sales by Application (2012-2017)
Table Middle East & Africa RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
Figure Middle East & Africa RNAi for Therapeutic Sales Market Share by Application (2012-2017)
Figure 2016 Middle East & Africa RNAi for Therapeutic Sales Market Share by Application
Table Middle East & Africa RNAi for Therapeutic Sales by Country (2012-2017)
Table Middle East & Africa RNAi for Therapeutic Sales Market Share by Country (2012-2017)
Figure Middle East & Africa RNAi for Therapeutic Sales Market Share by Country (2012-2017)
Figure 2016 Middle East & Africa RNAi for Therapeutic Sales Market Share by Country
Table Middle East & Africa RNAi for Therapeutic Import & Export (2012-2017)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Market Share (2012-2017)
Table Arrowhead Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arrowhead RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Arrowhead RNAi for Therapeutic Market Share (2012-2017)
Table Dicerna Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Dicerna Pharmaceuticals RNAi for Therapeutic Market Share (2012-2017)
Table Mirna Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mirna Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mirna Therapeutics RNAi for Therapeutic Market Share (2012-2017)
Table Quark Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Quark Pharmaceuticals RNAi for Therapeutic Market Share (2012-2017)
Table RXi Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure RXi Pharmaceuticals RNAi for Therapeutic Market Share (2012-2017)
Table miRagen Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table miRagen Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure miRagen Therapeutics RNAi for Therapeutic Market Share (2012-2017)
Table Gradalis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gradalis RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gradalis RNAi for Therapeutic Market Share (2012-2017)
Table Sirnaomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sirnaomics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sirnaomics RNAi for Therapeutic Market Share (2012-2017)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNAi for Therapeutic
Figure Manufacturing Process Analysis of RNAi for Therapeutic
Figure RNAi for Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of RNAi for Therapeutic Major Players in 2015
Table Major Buyers of RNAi for Therapeutic
Table Distributors/Traders List
Figure Global RNAi for Therapeutic Sales and Growth Rate Forecast (2017-2022)
Figure Global RNAi for Therapeutic Revenue and Growth Rate Forecast (2017-2022)
Table Global RNAi for Therapeutic Sales Forecast by Regions (2017-2022)
Table Global RNAi for Therapeutic Sales Market Share Forecast by Regions (2017-2022)
Table Global RNAi for Therapeutic Sales Forecast by Type (2017-2022)
Table Global RNAi for Therapeutic Sales Forecast by Application (2017-2022)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 治療用RNAiのトップ5メーカー分析(北米、欧州、アジア、南米、中東、アフリカ)(2017 Top 5 RNAi for Therapeutic Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆